Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 160

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Decreased levels of serum exosomal miR‐638 predict poor prognosis in hepatocellular carcinoma

Shi, Min, Jiang, Ye, Yang, Lu, Yan, Shushan, Wang, Yu‐Gang, Lu, Xiao‐Jie · 2018 · Journal of Cellular Biochemistry

Abstract

Currently available studies have implicated that exosome‐delivered microRNAs (miRNAs) play crucial roles in human cancer. However, the association of serum exosomal miR‐638 and hepatocellular carcinoma (HCC) remains largely unknown. We aim to investigate the expression of exosomal miR‐638 in serum of HCC patients and its prognostic role in this deadly disease. Kaplan‐Meier and Cox regression analyses were used to determine the survival of patients histologically diagnosed with HCC. Reduced levels of exosomal miR‐638 in serum samples from patients with HCC were identified by real‐time PCR. Negative association of serum exosomal miR‐638 with tumor size, vascular infiltration, and TNM stage was observed in HCC patients. Besides, the proliferation of Huh7 and SMCC7721 HCC cells were significantly inhibited when miR‐638 was over‐expressed in these cells. In addition, HCC patients with lower levels of serum exosomal miR‐638 had poor overall survival than those with higher levels of exosomal miR‐638 in serum. Our study strongly suggests that serum exosome‐delivered miR‐638 may serve as a novel circulating biomarker for HCC. Downregulation of miR‐638 predicts poor prognosis for patients with HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcb.26650

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 160

Metadata

Authors
Shi, M., Jiang, Y., Yang, L., Yan, S., Wang, Y., & Lu, X.
Venue
Journal of Cellular Biochemistry
Publisher
Wiley
Published
2018-03
Volume
119
Issue
6
Pages
4711-4716
ISSN
  • 0730-2312 (ISSN-L)
  • 1097-4644
OpenAlex
W2779328694
Cited by
160
References
3
FWCI
4.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.